A Phase III Randomized Clinical Trial: The Impact of Paclitaxel-Based Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (NLHIPEC) Followed by Sequential Intravenous Chemotherapy in Advanced High-Grade Serous Ovarian Cancer Patients - Interim Analysis of Safety and Immediate Efficacy from the C-HOC Trial
View ORCID ProfileQun Wang, Hua Liu, Yuhong Shen, Lifei Shen, Weiwei Feng
doi: https://doi.org/10.1101/2023.09.22.23295986
Qun Wang
1Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
MD/Ph DHua Liu
1Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
MD/Ph DYuhong Shen
1Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
MDLifei Shen
1Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
MDWeiwei Feng
1Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
MD/Ph D
Data Availability
Datasets utilized and analyzed during this study are available from the corresponding author upon reasonable request.
Posted October 05, 2023.
A Phase III Randomized Clinical Trial: The Impact of Paclitaxel-Based Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (NLHIPEC) Followed by Sequential Intravenous Chemotherapy in Advanced High-Grade Serous Ovarian Cancer Patients - Interim Analysis of Safety and Immediate Efficacy from the C-HOC Trial
Qun Wang, Hua Liu, Yuhong Shen, Lifei Shen, Weiwei Feng
medRxiv 2023.09.22.23295986; doi: https://doi.org/10.1101/2023.09.22.23295986
A Phase III Randomized Clinical Trial: The Impact of Paclitaxel-Based Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (NLHIPEC) Followed by Sequential Intravenous Chemotherapy in Advanced High-Grade Serous Ovarian Cancer Patients - Interim Analysis of Safety and Immediate Efficacy from the C-HOC Trial
Qun Wang, Hua Liu, Yuhong Shen, Lifei Shen, Weiwei Feng
medRxiv 2023.09.22.23295986; doi: https://doi.org/10.1101/2023.09.22.23295986
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)